Veterinary medicinal product register

The FVS registers website is using cookies. By continuing using this website you are agreeing to use cookies. Agree Cookies policy
Original name Strength Marketing authorisation number Marketing authorisation holder: ATCvet code Species More
Thyrotab 800 µg V/DCP/24/0004 CP-Pharma Handelsgesellschaft GmbH, Vācija QH03AA01 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Levothyroxine sodium
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release CP-Pharma Handelsgesellschaft GmbH, Vācija
Date of authorisation/renewal: 12-Jan-2024
Marketing authorisation valid until: 11-Jan-2029
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (12-Jan-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (12-Jan-2024)
Summary of product characteristics: [DOC] Zāļu_informācija_ZA_M_LI (12-Jan-2024)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/24/0004-01 800 µg/tabl. 3 AL/PVC-AL-PA blisteris, 10 tablete -
V/DCP/24/0004-02 800 µg/tabl. 10 AL/PVC-AL-PA blisteris, 10 tablete -
Thyrotab 600 µg V/DCP/24/0003 CP-Pharma Handelsgesellschaft GmbH, Vācija QH03AA01 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Levothyroxine sodium
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release CP-Pharma Handelsgesellschaft GmbH, Vācija
Date of authorisation/renewal: 12-Jan-2024
Marketing authorisation valid until: 11-Jan-2029
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (12-Jan-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (12-Jan-2024)
Summary of product characteristics: [DOC] Zāļu_informācija_ZA_M_LI (12-Jan-2024)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/24/0003-01 600 µg/tabl. 3 AL/PVC-AL-PA blisteris, 10 tablete -
V/DCP/24/0003-02 600 µg/tabl. 10 AL/PVC-AL-PA blisteris, 10 tablete -
Thyrotab 400 µg V/DCP/24/0002 CP-Pharma Handelsgesellschaft GmbH, Vācija QH03AA01 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Levothyroxine sodium
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release CP-Pharma Handelsgesellschaft GmbH, Vācija
Date of authorisation/renewal: 12-Jan-2024
Marketing authorisation valid until: 11-Jan-2029
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (12-Jan-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (12-Jan-2024)
Summary of product characteristics: [DOC] Zāļu_informācija_ZA_M_LI (12-Jan-2024)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/24/0002-01 400 µg/tabl. 3 AL/PVC-AL-PA blisteris, 10 tablete -
V/DCP/24/0002-02 400 µg/tabl. 10 AL/PVC-AL-PA blisteris, 10 tablete -
V/DCP/24/0002-03 400 µg/tabl. 25 AL/PVC-AL-PA blisteris, 10 tablete -
Thyrotab 200 µg V/DCP/24/0001 CP-Pharma Handelsgesellschaft GmbH, Vācija QH03AA01 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Levothyroxine sodium
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release CP-Pharma Handelsgesellschaft GmbH, Vācija
Date of authorisation/renewal: 12-Jan-2024
Marketing authorisation valid until: 11-Jan-2029
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (12-Jan-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (12-Jan-2024)
Summary of product characteristics: [DOC] Zāļu_informācija_ZA_M_LI (12-Jan-2024)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/24/0001-01 200 µg/tabl. 3 AL/PVC-AL-PA blisteris, 10 tablete -
V/DCP/24/0001-02 200 µg/tabl. 10 AL/PVC-AL-PA blisteris, 10 tablete -
V/DCP/24/0001-03 200 µg/tabl. 25 AL/PVC-AL-PA blisteris, 10 tablete -
Varroxal 0.71 g/g V/MRP/24/0010 Andermatt Biovet GmbH, Vācija QP53AG03 honey bees Vairāk

Medicinal product information

Pharmaceutical form: Powder for in-hive use
International name (active substance): Oxalic acid dihydrate
Distribution category: Nonprescription veterinary medicinal product
Manufacturer(s) responsible for batch release Andermatt Biovet GmbH, Vācija
Date of authorisation/renewal: 17-Jan-2024
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (17-Jan-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (17-Jan-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (17-Jan-2024)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/24/0010-01 0,71 g/g 10 Maisiņš, 2 g -
V/MRP/24/0010-02 0,71 g/g 50 Maisiņš, 2 g -
V/MRP/24/0010-03 0,71 g/g 1 ABPE pudelīte, 75 g -
V/MRP/24/0010-04 0,71 g/g 1 ABPE pudelīte, 200 g -
Tramsan 20 mg V/DCP/24/0015 Alfasan Nederland BV, Nīderlande QN02AX02 dogs Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Tramadol hydrochloride
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Alfasan Nederland BV, Nīderlande;Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 12-Feb-2024
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (12-Feb-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (12-Feb-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (12-Feb-2024)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/24/0015-01 1 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0015-02 2 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0015-03 3 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0015-04 4 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0015-05 5 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0015-06 6 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0015-07 7 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0015-08 8 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0015-09 9 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0015-10 10 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0015-11 12 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0015-12 25 PVH/PE/PVDH-Al blisteris, 10 tablete -
Tramsan 80 mg V/DCP/24/0016 Alfasan Nederland BV, Nīderlande QN02AX02 dogs Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Tramadol hydrochloride
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Alfasan Nederland BV, Nīderlande;Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 12-Feb-2024
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (12-Feb-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (12-Feb-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (12-Feb-2024)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/24/0016-01 1 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0016-02 2 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0016-03 3 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0016-04 4 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0016-05 5 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0016-06 6 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0016-07 7 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0016-08 8 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0016-09 9 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0016-10 10 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0016-11 12 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0016-12 25 PVH/PE/PVDH-Al blisteris, 10 tablete -
VETEGLAN 0.075 mg/ml V/SRP/23/0038 Laboratorios Calier, S.A., Spānija QG02AD90 sows; mares; cows Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): D-cloprostenol
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Laboratorios Calier, S.A., Spānija
Date of authorisation/renewal: 27-Jul-2023
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: SRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (27-Jul-2023)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (27-Jul-2023)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (23-Aug-2024)

Products

ID Strength Package size Primary packaging Labelling
V/SRP/23/0038-01 1 Stikla flakons, 10 ml -
V/SRP/23/0038-02 1 Stikla flakons, 20 ml -
Animedazon 2.45 % V/MRP/15/0020 aniMedica GmbH, Vācija QD06AA02 cattle; pigs; sheep Vairāk

Medicinal product information

Pharmaceutical form: cutaneous spray, suspension
International name (active substance): Chlortetracycline hydrochloride
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release aniMedica GmbH, Vācija
Date of authorisation/renewal: 27-May-2020
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (07-Feb-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (07-Feb-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (07-Feb-2024)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/15/0020-01 2,45 % 1 Pudele, 211 ml -
V/MRP/15/0020-02 2,45 % 12 Pudele, 211 ml -
Nobilis RT+IBmulti+G+ND - V/NRP/03/1535 Intervet International B.V., Nīderlande QI01AA06 chickens Vairāk

Medicinal product information

Pharmaceutical form: emulsion for injection
International name (active substance): Infectious Bronchitis virus strain,Inactivated infectious bronchitis virus, serotype Massachusetts, strain M41,Inactivated Newcastle disease virus, strain Clone 30,Inactivated infectious bursal disease virus, strain D78
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Intervet International Booxmer, Nīderlande
Date of authorisation/renewal: 15-Jul-2008
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (19-Oct-2023)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (19-Oct-2023)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (19-Oct-2023)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/03/1535-01 1 Flakons, 500 ml -
V/NRP/03/1535-02 1 Flakons, 250 ml -
Thyrovet 200 µg V/DCP/24/0005 CP-Pharma Handelsgesellschaft GmbH, Vācija QH03AA01 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Levothyroxine sodium
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release CP-Pharma Handelsgesellschaft GmbH, Vācija
Date of authorisation/renewal: 12-Jan-2024
Marketing authorisation valid until: 11-Jan-2029
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (12-Jan-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (12-Jan-2024)
Summary of product characteristics: [DOC] Zāļu_informācija_ZA_M_LI (28-Feb-2024)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/24/0005-01 200 µg/tabl. 3 AL/PVC-AL-PA blisteris, 10 tablete -
V/DCP/24/0005-02 200 µg/tabl. 10 AL/PVC-AL-PA blisteris, 10 tablete -
V/DCP/24/0005-03 200 µg/tabl. 25 AL/PVC-AL-PA blisteris, 10 tablete -
Thyrovet 400 µg V/DCP/24/0006 CP-Pharma Handelsgesellschaft GmbH, Vācija QH03AA01 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Levothyroxine sodium
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release CP-Pharma Handelsgesellschaft GmbH, Vācija
Date of authorisation/renewal: 12-Jan-2024
Marketing authorisation valid until: 11-Jan-2029
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (12-Jan-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (12-Jan-2024)
Summary of product characteristics: [DOC] Zāļu_informācija_ZA_M_LI (28-Feb-2024)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/24/0006-01 400 µg/tabl. 3 AL/PVC-AL-PA blisteris, 10 tablete -
V/DCP/24/0006-02 400 µg/tabl. 10 AL/PVC-AL-PA blisteris, 10 tablete -
V/DCP/24/0006-03 400 µg/tabl. 25 AL/PVC-AL-PA blisteris, 10 tablete -
Thyrovet 600 µg V/DCP/24/0007 CP-Pharma Handelsgesellschaft GmbH, Vācija QH03AA01 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Levothyroxine sodium
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release CP-Pharma Handelsgesellschaft GmbH, Vācija
Date of authorisation/renewal: 12-Jan-2024
Marketing authorisation valid until: 11-Jan-2029
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (12-Jan-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (12-Jan-2024)
Summary of product characteristics: [DOC] Zāļu_informācija_ZA_M_LI (28-Feb-2024)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/24/0007-01 600 µg/tabl. 3 AL/PVC-AL-PA blisteris, 10 tablete -
V/DCP/24/0007-02 600 µg/tabl. 10 AL/PVC-AL-PA blisteris, 10 tablete -
Ubrolexin - V/MRP/08/1587 Boehringer Ingelheim Vetmedica GmbH, Vācija QJ51RD01 cattle Vairāk

Medicinal product information

Pharmaceutical form: intramammary suspension
International name (active substance): Cefalexin,Kanamycin sulphate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Univet Ltd., Īrija
Date of authorisation/renewal: 07-Dec-2012
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (02-Oct-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (02-Oct-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (02-Oct-2025)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/08/1587-01 10 Injektors, 1 deva -
V/MRP/08/1587-02 20 Injektors, 1 deva -
EFICUR 50 mg/ml V/MRP/08/1604 Laboratorios Hipra S.A., Spānija QJ01DD90 cattle; pigs Vairāk

Medicinal product information

Pharmaceutical form: suspension for injection
International name (active substance): Ceftiofur (as ceftiofur hydrochloride)
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Laboratorios Hipra S.A., Spānija
Date of authorisation/renewal: 02-Mar-2012
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (01-Oct-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (01-Oct-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (01-Oct-2025)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/08/1604-01 50 mg/ml 1 Stikla pudelīte, 100 ml -
V/MRP/08/1604-02 50 mg/ml 1 Stikla pudelīte, 250 ml -
V/MRP/08/1604-03 50 mg/ml 10 Stikla flakons, 100 ml -
V/MRP/08/1604-05 50 mg/ml 1 Stikla pudelīte, 50 ml -
V/MRP/08/1604-06 50 mg/ml 12 Stikla pudele, 100 ml -
V/MRP/08/1604-07 50 mg/ml 1 Polietilēna pudele, 50 ml -
V/MRP/08/1604-08 50 mg/ml 1 Polietilēna pudele, 100 ml -
V/MRP/08/1604-09 50 mg/ml 1 Polietilēna pudele, 250 ml -
Fypryst Combo 402mg/361,8mg - V/DCP/14/0013 KRKA, d.d., Novo mesto, Slovēnija QP53AX65 very large dogs Vairāk

Medicinal product information

Pharmaceutical form: spot-on solution
International name (active substance): Fipronil,S-Methoprene
Distribution category: Nonprescription veterinary medicinal product
Manufacturer(s) responsible for batch release KRKA, d.d., Novo mesto, Slovēnija
Date of authorisation/renewal: 27-Feb-2019
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (22-Sep-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (22-Sep-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (22-Sep-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/14/0013-01 1 Polipropilēna pipete, 1 deva -
V/DCP/14/0013-02 3 Polipropilēna pipete, 1 deva -
V/DCP/14/0013-03 6 Polipropilēna pipete, 1 deva -
V/DCP/14/0013-04 10 Polipropilēna pipete, 1 deva [PDF]
Pereprin 5 mg/ml V/DCP/25/0077 Huvepharma NV, Beļģija QP54AA04 cattle; sheep; goats Vairāk

Medicinal product information

Pharmaceutical form: pour-on solution
International name (active substance): Eprinomectin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Biovet AD, Bulgārija
Date of authorisation/renewal: 12-Dec-2025
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (12-Dec-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (12-Dec-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (12-Dec-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/25/0077-01 1 ABPE pudele, 250 ml -
V/DCP/25/0077-02 1 ABPE pudele, 1 l -
V/DCP/25/0077-03 1 ABPE pudele, 2,5 l -
V/DCP/25/0077-04 1 ABPE pudele, 5 l -
TOP SPOT ON STRONGER sol. ad us. vet. 650 mg/ml V/NRP/03/1590 Bioveta, a.s., Čehija QP53AC04 horses; dogs Vairāk

Medicinal product information

Pharmaceutical form: spot-on solution
International name (active substance): Permethrin
Distribution category: Nonprescription veterinary medicinal product
Manufacturer(s) responsible for batch release Bioveta, a.s., Čehija
Date of authorisation/renewal: 22-Oct-2008
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [DOC] 43-270209LI (09-Mar-2009)
Labelling text: [DOC] 09032009M (09-Mar-2009)
Summary of product characteristics: [DOC] 43-270209ZA (09-Mar-2009)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/03/1590-01 650 mg/ml 1 Kontūriepakojums, 1 ml -
V/NRP/03/1590-02 650 mg/ml 2 Kontūriepakojums, 1 ml -
V/NRP/03/1590-03 650 mg/ml 3 Kontūriepakojums, 1 ml -
V/NRP/03/1590-04 650 mg/ml 25 Kontūriepakojums, 1 ml -
V/NRP/03/1590-05 650 mg/ml 50 Kontūriepakojums, 1 ml -
V/NRP/03/1590-06 650 mg/ml 100 Kontūriepakojums, 1 ml -
V/NRP/03/1590-07 650 mg/ml 1 Kontūriepakojums, 25 ml -
V/NRP/03/1590-08 650 mg/ml 6 Kontūriepakojums, 25 ml -
Cartaxx 20 mg V/DCP/25/0073 Alfasan Nederland BV, Nīderlande QM01AE91 dogs Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Carprofen
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 10-Dec-2025
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (10-Dec-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (10-Dec-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (10-Dec-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/25/0073-01 1 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/25/0073-02 2 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/25/0073-03 3 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/25/0073-04 4 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/25/0073-05 5 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/25/0073-06 6 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/25/0073-07 7 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/25/0073-08 8 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/25/0073-09 9 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/25/0073-10 10 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/25/0073-11 12 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/25/0073-12 25 PVH/PE/PVDH-Al blisteris, 10 tablete -
Cartaxx 50 mg V/DCP/25/0074 Alfasan Nederland BV, Nīderlande QM01AE91 dogs Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Carprofen
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 10-Dec-2025
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (10-Dec-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (10-Dec-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (10-Dec-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/25/0074-01 1 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/25/0074-02 2 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/25/0074-03 3 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/25/0074-04 4 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/25/0074-05 5 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/25/0074-06 6 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/25/0074-07 7 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/25/0074-08 8 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/25/0074-09 9 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/25/0074-10 10 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/25/0074-11 12 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/25/0074-12 25 PVH/PE/PVDH-Al blisteris, 10 tablete -

3082 records

© Food and veterinary service · 2026 Cookies policy